Global Human Immunodeficiency Virus Type-1 Market Growth (Status and Outlook) 2024-2030

The global Human Immunodeficiency Virus Type-1 market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Human Immunodeficiency Virus Type-1 Industry Forecast” looks at past sales and reviews total world Human Immunodeficiency Virus Type-1 sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Immunodeficiency Virus Type-1 sales for 2023 through 2029. With Human Immunodeficiency Virus Type-1 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Immunodeficiency Virus Type-1 industry.

This Insight Report provides a comprehensive analysis of the global Human Immunodeficiency Virus Type-1 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Immunodeficiency Virus Type-1 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Immunodeficiency Virus Type-1 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Immunodeficiency Virus Type-1 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Immunodeficiency Virus Type-1.

United States market for Human Immunodeficiency Virus Type-1 is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Human Immunodeficiency Virus Type-1 is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Human Immunodeficiency Virus Type-1 is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Human Immunodeficiency Virus Type-1 players cover Roche, Bristol Myers Squibb, Merck & Co. Inc., GSK, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Immunodeficiency Virus Type-1 market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
    Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
    Protease Inhibitors (PIs)
    Integrase Inhibitor
    Others

Segmentation by Application:
    Hospital Pharmacies
    Retail Pharmacies

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Segmentation by Type:
    Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
    Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
    Protease Inhibitors (PIs)
    Integrase Inhibitor
    Others

Segmentation by Application:
    Hospital Pharmacies
    Retail Pharmacies

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Roche
    Bristol Myers Squibb
    Merck & Co. Inc.
    GSK
    Pfizer
    Viatris
    Sanofi
    AstraZeneca
    Novartis
    Bayer

List of Tables
 Table 1. Human Immunodeficiency Virus Type-1 Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
 Table 2. Human Immunodeficiency Virus Type-1 Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
 Table 3. Major Players of Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
 Table 4. Major Players of Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
 Table 5. Major Players of Protease Inhibitors (PIs)
 Table 6. Major Players of Integrase Inhibitor
 Table 7. Major Players of Others
 Table 8. Human Immunodeficiency Virus Type-1 Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
 Table 9. Global Human Immunodeficiency Virus Type-1 Market Size by Type (2019-2024) & ($ millions)
 Table 10. Global Human Immunodeficiency Virus Type-1 Market Size Market Share by Type (2019-2024)
 Table 11. Human Immunodeficiency Virus Type-1 Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
 Table 12. Global Human Immunodeficiency Virus Type-1 Market Size by Application (2019-2024) & ($ millions)
 Table 13. Global Human Immunodeficiency Virus Type-1 Market Size Market Share by Application (2019-2024)
 Table 14. Global Human Immunodeficiency Virus Type-1 Revenue by Player (2019-2024) & ($ millions)
 Table 15. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Player (2019-2024)
 Table 16. Human Immunodeficiency Virus Type-1 Key Players Head office and Products Offered
 Table 17. Human Immunodeficiency Virus Type-1 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
 Table 18. New Products and Potential Entrants
 Table 19. Mergers & Acquisitions, Expansion
 Table 20. Global Human Immunodeficiency Virus Type-1 Market Size by Region (2019-2024) & ($ millions)
 Table 21. Global Human Immunodeficiency Virus Type-1 Market Size Market Share by Region (2019-2024)
 Table 22. Global Human Immunodeficiency Virus Type-1 Revenue by Country/Region (2019-2024) & ($ millions)
 Table 23. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Country/Region (2019-2024)
 Table 24. Americas Human Immunodeficiency Virus Type-1 Market Size by Country (2019-2024) & ($ millions)
 Table 25. Americas Human Immunodeficiency Virus Type-1 Market Size Market Share by Country (2019-2024)
 Table 26. Americas Human Immunodeficiency Virus Type-1 Market Size by Type (2019-2024) & ($ millions)
 Table 27. Americas Human Immunodeficiency Virus Type-1 Market Size Market Share by Type (2019-2024)
 Table 28. Americas Human Immunodeficiency Virus Type-1 Market Size by Application (2019-2024) & ($ millions)
 Table 29. Americas Human Immunodeficiency Virus Type-1 Market Size Market Share by Application (2019-2024)
 Table 30. APAC Human Immunodeficiency Virus Type-1 Market Size by Region (2019-2024) & ($ millions)
 Table 31. APAC Human Immunodeficiency Virus Type-1 Market Size Market Share by Region (2019-2024)
 Table 32. APAC Human Immunodeficiency Virus Type-1 Market Size by Type (2019-2024) & ($ millions)
 Table 33. APAC Human Immunodeficiency Virus Type-1 Market Size by Application (2019-2024) & ($ millions)
 Table 34. Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2019-2024) & ($ millions)
 Table 35. Europe Human Immunodeficiency Virus Type-1 Market Size Market Share by Country (2019-2024)
 Table 36. Europe Human Immunodeficiency Virus Type-1 Market Size by Type (2019-2024) & ($ millions)
 Table 37. Europe Human Immunodeficiency Virus Type-1 Market Size by Application (2019-2024) & ($ millions)
 Table 38. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Region (2019-2024) & ($ millions)
 Table 39. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Type (2019-2024) & ($ millions)
 Table 40. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Application (2019-2024) & ($ millions)
 Table 41. Key Market Drivers & Growth Opportunities of Human Immunodeficiency Virus Type-1
 Table 42. Key Market Challenges & Risks of Human Immunodeficiency Virus Type-1
 Table 43. Key Industry Trends of Human Immunodeficiency Virus Type-1
 Table 44. Global Human Immunodeficiency Virus Type-1 Market Size Forecast by Region (2025-2030) & ($ millions)
 Table 45. Global Human Immunodeficiency Virus Type-1 Market Size Market Share Forecast by Region (2025-2030)
 Table 46. Global Human Immunodeficiency Virus Type-1 Market Size Forecast by Type (2025-2030) & ($ millions)
 Table 47. Global Human Immunodeficiency Virus Type-1 Market Size Forecast by Application (2025-2030) & ($ millions)
 Table 48. Roche Details, Company Type, Human Immunodeficiency Virus Type-1 Area Served and Its Competitors
 Table 49. Roche Human Immunodeficiency Virus Type-1 Product Offered
 Table 50. Roche Human Immunodeficiency Virus Type-1 Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 51. Roche Main Business
 Table 52. Roche Latest Developments
 Table 53. Bristol Myers Squibb Details, Company Type, Human Immunodeficiency Virus Type-1 Area Served and Its Competitors
 Table 54. Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Product Offered
 Table 55. Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 56. Bristol Myers Squibb Main Business
 Table 57. Bristol Myers Squibb Latest Developments
 Table 58. Merck & Co. Inc. Details, Company Type, Human Immunodeficiency Virus Type-1 Area Served and Its Competitors
 Table 59. Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Product Offered
 Table 60. Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 61. Merck & Co. Inc. Main Business
 Table 62. Merck & Co. Inc. Latest Developments
 Table 63. GSK Details, Company Type, Human Immunodeficiency Virus Type-1 Area Served and Its Competitors
 Table 64. GSK Human Immunodeficiency Virus Type-1 Product Offered
 Table 65. GSK Human Immunodeficiency Virus Type-1 Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 66. GSK Main Business
 Table 67. GSK Latest Developments
 Table 68. Pfizer Details, Company Type, Human Immunodeficiency Virus Type-1 Area Served and Its Competitors
 Table 69. Pfizer Human Immunodeficiency Virus Type-1 Product Offered
 Table 70. Pfizer Human Immunodeficiency Virus Type-1 Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 71. Pfizer Main Business
 Table 72. Pfizer Latest Developments
 Table 73. Viatris Details, Company Type, Human Immunodeficiency Virus Type-1 Area Served and Its Competitors
 Table 74. Viatris Human Immunodeficiency Virus Type-1 Product Offered
 Table 75. Viatris Human Immunodeficiency Virus Type-1 Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 76. Viatris Main Business
 Table 77. Viatris Latest Developments
 Table 78. Sanofi Details, Company Type, Human Immunodeficiency Virus Type-1 Area Served and Its Competitors
 Table 79. Sanofi Human Immunodeficiency Virus Type-1 Product Offered
 Table 80. Sanofi Human Immunodeficiency Virus Type-1 Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 81. Sanofi Main Business
 Table 82. Sanofi Latest Developments
 Table 83. AstraZeneca Details, Company Type, Human Immunodeficiency Virus Type-1 Area Served and Its Competitors
 Table 84. AstraZeneca Human Immunodeficiency Virus Type-1 Product Offered
 Table 85. AstraZeneca Human Immunodeficiency Virus Type-1 Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 86. AstraZeneca Main Business
 Table 87. AstraZeneca Latest Developments
 Table 88. Novartis Details, Company Type, Human Immunodeficiency Virus Type-1 Area Served and Its Competitors
 Table 89. Novartis Human Immunodeficiency Virus Type-1 Product Offered
 Table 90. Novartis Human Immunodeficiency Virus Type-1 Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 91. Novartis Main Business
 Table 92. Novartis Latest Developments
 Table 93. Bayer Details, Company Type, Human Immunodeficiency Virus Type-1 Area Served and Its Competitors
 Table 94. Bayer Human Immunodeficiency Virus Type-1 Product Offered
 Table 95. Bayer Human Immunodeficiency Virus Type-1 Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 96. Bayer Main Business
 Table 97. Bayer Latest Developments


List of Figures
 Figure 1. Human Immunodeficiency Virus Type-1 Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Human Immunodeficiency Virus Type-1 Market Size Growth Rate 2019-2030 ($ millions)
 Figure 6. Human Immunodeficiency Virus Type-1 Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
 Figure 7. Human Immunodeficiency Virus Type-1 Sales Market Share by Country/Region (2023)
 Figure 8. Human Immunodeficiency Virus Type-1 Sales Market Share by Country/Region (2019, 2023 & 2030)
 Figure 9. Global Human Immunodeficiency Virus Type-1 Market Size Market Share by Type in 2023
 Figure 10. Human Immunodeficiency Virus Type-1 in Hospital Pharmacies
 Figure 11. Global Human Immunodeficiency Virus Type-1 Market: Hospital Pharmacies (2019-2024) & ($ millions)
 Figure 12. Human Immunodeficiency Virus Type-1 in Retail Pharmacies
 Figure 13. Global Human Immunodeficiency Virus Type-1 Market: Retail Pharmacies (2019-2024) & ($ millions)
 Figure 14. Global Human Immunodeficiency Virus Type-1 Market Size Market Share by Application in 2023
 Figure 15. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Player in 2023
 Figure 16. Global Human Immunodeficiency Virus Type-1 Market Size Market Share by Region (2019-2024)
 Figure 17. Americas Human Immunodeficiency Virus Type-1 Market Size 2019-2024 ($ millions)
 Figure 18. APAC Human Immunodeficiency Virus Type-1 Market Size 2019-2024 ($ millions)
 Figure 19. Europe Human Immunodeficiency Virus Type-1 Market Size 2019-2024 ($ millions)
 Figure 20. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size 2019-2024 ($ millions)
 Figure 21. Americas Human Immunodeficiency Virus Type-1 Value Market Share by Country in 2023
 Figure 22. United States Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 23. Canada Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 24. Mexico Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 25. Brazil Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 26. APAC Human Immunodeficiency Virus Type-1 Market Size Market Share by Region in 2023
 Figure 27. APAC Human Immunodeficiency Virus Type-1 Market Size Market Share by Type (2019-2024)
 Figure 28. APAC Human Immunodeficiency Virus Type-1 Market Size Market Share by Application (2019-2024)
 Figure 29. China Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 30. Japan Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 31. South Korea Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 32. Southeast Asia Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 33. India Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 34. Australia Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 35. Europe Human Immunodeficiency Virus Type-1 Market Size Market Share by Country in 2023
 Figure 36. Europe Human Immunodeficiency Virus Type-1 Market Size Market Share by Type (2019-2024)
 Figure 37. Europe Human Immunodeficiency Virus Type-1 Market Size Market Share by Application (2019-2024)
 Figure 38. Germany Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 39. France Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 40. UK Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 41. Italy Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 42. Russia Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 43. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size Market Share by Region (2019-2024)
 Figure 44. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size Market Share by Type (2019-2024)
 Figure 45. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size Market Share by Application (2019-2024)
 Figure 46. Egypt Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 47. South Africa Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 48. Israel Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 49. Turkey Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 50. GCC Countries Human Immunodeficiency Virus Type-1 Market Size Growth 2019-2024 ($ millions)
 Figure 51. Americas Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 52. APAC Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 53. Europe Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 54. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 55. United States Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 56. Canada Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 57. Mexico Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 58. Brazil Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 59. China Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 60. Japan Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 61. Korea Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 62. Southeast Asia Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 63. India Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 64. Australia Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 65. Germany Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 66. France Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 67. UK Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 68. Italy Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 69. Russia Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 70. Egypt Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 71. South Africa Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 72. Israel Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 73. Turkey Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 74. GCC Countries Human Immunodeficiency Virus Type-1 Market Size 2025-2030 ($ millions)
 Figure 75. Global Human Immunodeficiency Virus Type-1 Market Size Market Share Forecast by Type (2025-2030)
 Figure 76. Global Human Immunodeficiency Virus Type-1 Market Size Market Share Forecast by Application (2025-2030)

Roche
Bristol Myers Squibb
Merck & Co. Inc.
GSK
Pfizer
Viatris
Sanofi
AstraZeneca
Novartis
Bayer

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape